AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
201.55
-1.16 (-0.57%)
At close: May 8, 2026, 4:00 PM EDT
201.38
-0.17 (-0.08%)
After-hours: May 8, 2026, 7:57 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
The 17 analysts that cover AbbVie stock have a consensus rating of "Buy" and an average price target of $254.82, which forecasts a 26.43% increase in the stock price over the next year. The lowest target is $220 and the highest is $294.
Price Target: $254.82 (+26.43%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 5 | 5 |
| Buy | 9 | 9 | 10 | 10 | 9 | 9 |
| Hold | 5 | 7 | 6 | 6 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 21 | 20 | 20 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $232 → $236 | Buy | Maintains | $232 → $236 | +17.09% | May 4, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $249 | Strong Buy | Reiterates | $249 | +23.54% | May 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $262 → $265 | Strong Buy | Maintains | $262 → $265 | +31.48% | Apr 30, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $270 → $278 | Buy | Maintains | $270 → $278 | +37.93% | Apr 30, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $240 | Buy | Reiterates | $240 | +19.08% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
68.60B
from 61.16B
Increased by 12.17%
Revenue Next Year
74.23B
from 68.60B
Increased by 8.20%
EPS This Year
14.53
from 2.36
Increased by 515.59%
EPS Next Year
16.49
from 14.53
Increased by 13.48%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 71.1B | 79.3B | ||||||
| Avg | 68.6B | 74.2B | ||||||
| Low | 65.5B | 69.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 16.2% | 15.6% | ||||||
| Avg | 12.2% | 8.2% | ||||||
| Low | 7.2% | 0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 15.55 | 18.30 | ||||||
| Avg | 14.53 | 16.49 | ||||||
| Low | 13.79 | 14.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 558.9% | 26.0% | ||||||
| Avg | 515.6% | 13.5% | ||||||
| Low | 484.3% | 0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.